EVOLVE-HBV (Evaluation of Vukuzazi LiVEr disease - Hepatitis B): A retrospective serosurvey of Hepatitis B Virus (HBV) infection, exposure, and vaccine-mediated immunity using archived samples from the Vukuzazi Study (2018-2020).

South Africa, 2018 - 2020

Reference ID

AHRI.EVOLVE.HBV

Producer(s)

Siyabonga Nxumalo, Lusanda Mazibuko, Nompumelelo Mkwanazi, Prof Philippa C Matthews, Prof Collins Iwuji, Dr Motswedi Anderson, Kathy Baisley, Gregory Ording-Jespersen, Mark Siedner, Emily Wong, Willem Hanekom, Vukuzazi Field Team, Sample Processing Unit, Khanyi Msomi, Theresa Smit, Dickman Gareta,

Metadata

Documentation in PDF DDI/XML JSON

Created on

Jul 14, 2026

Last modified

Jul 14, 2026

Page views

915

Downloads

Liquid Culture Result(MGIT) (liquidculture)

Data file: vk_evolve

Overview

Valid: 1091

Invalid: 1109

Type: Discrete

Decimal: 0

Width: 10

Range: 1 - 7

Format: Numeric

Questions and instructions

Categories

Value	Category	Cases
1	Negative MTB Not Isolated	993	91%
2	Positive MTB Only(Mycobacterium Tuberculosis isolated)	12	1.1%
3	Positive NTM Only	23	2.1%
4	Culture Contaminated	49	4.5%
5	Positive MTB And Contaminated(Mycobacterium Tuberculosis isolated)	0	0%
6	Positive NTM And contaminated	14	1.3%
7	Positive MTB And Positive NTM(Mycobacterium Tuberculosis isolated)	0	0%
Sysmiss		1109

Warning: these figures indicate the number of cases found in the data file. They cannot be interpreted as summary statistics of the population of interest.

Back to Catalog